{
    "nct_id": "NCT03602885",
    "official_title": "EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options - RCT of Usual Chemotherapy Educational Tools Versus Investigational Chemotherapy Educational Tools",
    "inclusion_criteria": "* Self-identify as Hispanic/Latino\n* Has been diagnosed with metastatic colorectal cancer (mCRC) OR locally advanced pancreatic cancer (LAPC) OR metastatic pancreatic cancer (mPC) AND is making a decision regarding treatment with 1st line palliative chemotherapy\n* Treating oncologist has recommended consideration of one or more of the regimens for which we have developed chemotherapy educational (CEI) toolkits\n\n  * For mCRC: FOLFOX, FOLFOX + bevacizumab, FOLFIRI, FOLFIRI + bevacizumab\n  * For LAPC or mPC: FOLFIRINOX, Gemcitabine, or Gemcitabine + nab-paclitaxel\n  * Patients who are also considering treatment on a clinical trial of one of these regimens +/- an investigational agent would still be eligible, so long as the treating MD believes to the content of the CEI to be relevant to the trial regimen.\n* Planning to receive treatment at the enrolling site\n* Age ≥ 21\n* English or Spanish proficient\n\nCaregiver Inclusion Criteria:\n\n* Caregivers of eligible patient participants\n* Age ≥ 21\n* English or Spanish proficient\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* For mCRC patients: Patients with oligometastatic disease who have a definitive plan for curative surgical resection are not eligible.\n* Significant delirium/dementia as judged by the treating oncologist",
    "miscellaneous_criteria": "Patient"
}